Regado Biosciences Inc. (RGDO) News Nov 20, 2014,
Post# of 250675
Posted On: 11/21/2014 5:01:51 AM
Regado Biosciences Inc. (RGDO) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on RGDO
Burger King soars, Amazon buys Twitch, Apple eyes another record close 1:35 p.m. Aug. 25, 2014 - Angela Johnson
Regado Biosciences shares plunge 51% after drug trial terminated 8:34 a.m. Aug. 25, 2014 - Tomi Kilgore
Regado Biosciences shares tumble 38% premarket after drug trial halted 7:02 a.m. Aug. 25, 2014 - Tomi Kilgore
Regado Biosciences terminates blood-clot drug study 6:59 a.m. Aug. 25, 2014 - Michael Calia
PetSmart gains on Jana stake; Lorillard rallies 12:37 p.m. July 3, 2014 - Sue Chang
Regado Biosciences price target dropped to $2 from $10 by Wedbush 7:02 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences cut to underperform from outperform by Wedbush 7:02 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences nearly halved after announcing trial review 6:24 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences shares drop 39% in premarket trade 6:07 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences prices secondary offering at $6 a share 6:43 a.m. April 11, 2014 - Ciara Linnane
CORRECTED: Regado Biosciences prices secondary offering at $6 a share 6:42 a.m. April 11, 2014 - Ciara Linnane
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Other News on RGDO
Biotech Weekly: Here Come The Institutional Holdings Updates 8:31 a.m. Nov. 17, 2014 - Seeking Alpha
Regado Biosciences' (RGDO) CEO Michael Metzger on Q3 2014 Results - Earnings Call Transcript 10:17 a.m. Nov. 6, 2014 - Seeking Alpha
Regado Biosciences: Significant Value Remains After Lead Drug Failure 7:50 a.m. Oct. 28, 2014 - Seeking Alpha
CorMedix Files IND Application for Neutrolin in the US - Analyst Blog 5:10 p.m. Sept. 30, 2014 - Zacks.com
Regado Trims Workforce, Revamps Strategy on Trial Halt - Analyst Blog 4:30 p.m. Sept. 30, 2014 - Zacks.com
Regado Trims Workforce, Revamps Strategy on Trial Halt - Analyst Blog 4:30 p.m. Sept. 30, 2014 - Zacks.com
Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog 6:27 p.m. Sept. 25, 2014 - Zacks.com
Regado laying off 60% of workforce, exploring options 6:10 p.m. Sept. 24, 2014 - Seeking Alpha
Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog 6:10 p.m. Sept. 24, 2014 - Zacks.com
Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog 6:10 p.m. Sept. 24, 2014 - Zacks.com
Is Merck KGaA on Track with its "Fit for 2018" Program? - Analyst Blog 2:50 p.m. Sept. 19, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
QLT Unveils Positive Retreatment Study Data - Analyst Blog 6:50 p.m. Sept. 15, 2014 - Zacks.com
Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog 5:25 p.m. Sept. 12, 2014 - Zacks.com
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog 5:30 p.m. Sept. 9, 2014 - Zacks.com
OncoMed's Shares Gain on Lifting of Partial Clinical Hold - Analyst Blog 6:00 p.m. Sept. 8, 2014 - Zacks.com
Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog 4:45 p.m. Sept. 5, 2014 - Zacks.com
Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog 5:00 p.m. Sept. 4, 2014 - Zacks.com
HMS Holdings (HMSY) Slumps: Stock Falls by 10.2% - Tale of the Tape 8:34 a.m. Sept. 4, 2014 - Zacks.com
Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog 5:10 p.m. Sept. 2, 2014 - Zacks.com
Press Releases on RGDO
Regado Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update 4:30 p.m. Nov. 5, 2014 - PR Newswire - PRF
Regado Biosciences to Provide Third Quarter 2014 Financial Results 6:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Regado Biosciences Appoints Michael A. Metzger CEO 6:30 a.m. Oct. 10, 2014 - PR Newswire - PRF
Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma, Pharmacyclics, and Raptor Pharma 7:45 a.m. Sept. 26, 2014 - PR Newswire - PRF
Regado Biosciences Announces Workforce Reduction and Provides Update on Strategic Direction 3:53 p.m. Sept. 24, 2014 - PR Newswire - PRF
Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 8:55 a.m. Sept. 19, 2014 - PR Newswire - PRF
Upcoming Deadline: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 6:13 p.m. Sept. 2, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 3:35 p.m. Aug. 27, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Reminds Regado Biosciences, Inc. Investors of Important September 8, 2014 Class Action Deadline - RGDO 8:50 p.m. Aug. 25, 2014 - BusinessWire - BZX
Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial 5:30 a.m. Aug. 25, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Regado Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- RGDO 5:00 a.m. Aug. 25, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 10:10 a.m. Aug. 20, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Regado Biosciences, Inc. to Contact Brower Piven Before the September 8, 2014 Lead Plaintiff Deadline In Class Action Lawsuit 7:10 p.m. Aug. 19, 2014 - BusinessWire - BZX
Regado Biosciences Announces Second Quarter 2014 Financial Results and Corporate Highlights 3:30 p.m. Aug. 11, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Regado Biosciences, Inc. and Certain Officers - RGDO 3:57 p.m. Aug. 8, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 8:41 a.m. Aug. 8, 2014 - GlobeNewswire
EQUITY ALERT: Rosen Law Firm Reminds Regado Biosciences, Inc. Investors of Important Class Action Deadline - RGDO 11:12 a.m. Aug. 5, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Regado Biosciences, Inc. to Contact Brower Piven Before the September 8, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RGDO 4:02 p.m. July 30, 2014 - GlobeNewswire
Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3:10 p.m. July 29, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Regado Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- RGDO 5:00 p.m. July 25, 2014 - GlobeNewswire
MarketWatch News on RGDO
Burger King soars, Amazon buys Twitch, Apple eyes another record close 1:35 p.m. Aug. 25, 2014 - Angela Johnson
Regado Biosciences shares plunge 51% after drug trial terminated 8:34 a.m. Aug. 25, 2014 - Tomi Kilgore
Regado Biosciences shares tumble 38% premarket after drug trial halted 7:02 a.m. Aug. 25, 2014 - Tomi Kilgore
Regado Biosciences terminates blood-clot drug study 6:59 a.m. Aug. 25, 2014 - Michael Calia
PetSmart gains on Jana stake; Lorillard rallies 12:37 p.m. July 3, 2014 - Sue Chang
Regado Biosciences price target dropped to $2 from $10 by Wedbush 7:02 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences cut to underperform from outperform by Wedbush 7:02 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences nearly halved after announcing trial review 6:24 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences shares drop 39% in premarket trade 6:07 a.m. July 3, 2014 - Tomi Kilgore
Regado Biosciences prices secondary offering at $6 a share 6:43 a.m. April 11, 2014 - Ciara Linnane
CORRECTED: Regado Biosciences prices secondary offering at $6 a share 6:42 a.m. April 11, 2014 - Ciara Linnane
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Other News on RGDO
Biotech Weekly: Here Come The Institutional Holdings Updates 8:31 a.m. Nov. 17, 2014 - Seeking Alpha
Regado Biosciences' (RGDO) CEO Michael Metzger on Q3 2014 Results - Earnings Call Transcript 10:17 a.m. Nov. 6, 2014 - Seeking Alpha
Regado Biosciences: Significant Value Remains After Lead Drug Failure 7:50 a.m. Oct. 28, 2014 - Seeking Alpha
CorMedix Files IND Application for Neutrolin in the US - Analyst Blog 5:10 p.m. Sept. 30, 2014 - Zacks.com
Regado Trims Workforce, Revamps Strategy on Trial Halt - Analyst Blog 4:30 p.m. Sept. 30, 2014 - Zacks.com
Regado Trims Workforce, Revamps Strategy on Trial Halt - Analyst Blog 4:30 p.m. Sept. 30, 2014 - Zacks.com
Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog 6:27 p.m. Sept. 25, 2014 - Zacks.com
Regado laying off 60% of workforce, exploring options 6:10 p.m. Sept. 24, 2014 - Seeking Alpha
Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog 6:10 p.m. Sept. 24, 2014 - Zacks.com
Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog 6:10 p.m. Sept. 24, 2014 - Zacks.com
Is Merck KGaA on Track with its "Fit for 2018" Program? - Analyst Blog 2:50 p.m. Sept. 19, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
QLT Unveils Positive Retreatment Study Data - Analyst Blog 6:50 p.m. Sept. 15, 2014 - Zacks.com
Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog 5:25 p.m. Sept. 12, 2014 - Zacks.com
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog 5:30 p.m. Sept. 9, 2014 - Zacks.com
OncoMed's Shares Gain on Lifting of Partial Clinical Hold - Analyst Blog 6:00 p.m. Sept. 8, 2014 - Zacks.com
Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog 4:45 p.m. Sept. 5, 2014 - Zacks.com
Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog 5:00 p.m. Sept. 4, 2014 - Zacks.com
HMS Holdings (HMSY) Slumps: Stock Falls by 10.2% - Tale of the Tape 8:34 a.m. Sept. 4, 2014 - Zacks.com
Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog 5:10 p.m. Sept. 2, 2014 - Zacks.com
Press Releases on RGDO
Regado Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update 4:30 p.m. Nov. 5, 2014 - PR Newswire - PRF
Regado Biosciences to Provide Third Quarter 2014 Financial Results 6:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Regado Biosciences Appoints Michael A. Metzger CEO 6:30 a.m. Oct. 10, 2014 - PR Newswire - PRF
Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma, Pharmacyclics, and Raptor Pharma 7:45 a.m. Sept. 26, 2014 - PR Newswire - PRF
Regado Biosciences Announces Workforce Reduction and Provides Update on Strategic Direction 3:53 p.m. Sept. 24, 2014 - PR Newswire - PRF
Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems 8:55 a.m. Sept. 19, 2014 - PR Newswire - PRF
Upcoming Deadline: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 6:13 p.m. Sept. 2, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 3:35 p.m. Aug. 27, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Reminds Regado Biosciences, Inc. Investors of Important September 8, 2014 Class Action Deadline - RGDO 8:50 p.m. Aug. 25, 2014 - BusinessWire - BZX
Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial 5:30 a.m. Aug. 25, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Regado Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- RGDO 5:00 a.m. Aug. 25, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 10:10 a.m. Aug. 20, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Regado Biosciences, Inc. to Contact Brower Piven Before the September 8, 2014 Lead Plaintiff Deadline In Class Action Lawsuit 7:10 p.m. Aug. 19, 2014 - BusinessWire - BZX
Regado Biosciences Announces Second Quarter 2014 Financial Results and Corporate Highlights 3:30 p.m. Aug. 11, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Regado Biosciences, Inc. and Certain Officers - RGDO 3:57 p.m. Aug. 8, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO 8:41 a.m. Aug. 8, 2014 - GlobeNewswire
EQUITY ALERT: Rosen Law Firm Reminds Regado Biosciences, Inc. Investors of Important Class Action Deadline - RGDO 11:12 a.m. Aug. 5, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Regado Biosciences, Inc. to Contact Brower Piven Before the September 8, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RGDO 4:02 p.m. July 30, 2014 - GlobeNewswire
Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3:10 p.m. July 29, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Regado Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- RGDO 5:00 p.m. July 25, 2014 - GlobeNewswire
(0)
(0)